Gene expression data from CD34+ BMMCs/PBMCs from JAK2V617F positive MPN patients vs. Healthy controls

Philadelphia chromosome-negative myeloproliferative neoplasms (MPN) consist of primary myelofibrosis (PMF), polycythemia vera (PV), essential thrombocythemia (ET) and seconday myelofibrosis (pPV-MF or pET-MF) In this dataset, we compare the gene expression data of bone marrow (BM) or peripheral blood (PB) mononuclear cells of CD34+ cells from JAK2V617F mutated patients vs. healthy donors 19 JAK2V617F MPN patients and 6 healthy controls were analyzed

费城染色体阴性骨髓增殖性肿瘤（Philadelphia chromosome-negative myeloproliferative neoplasms, MPN）包含原发性骨髓纤维化（PMF）、真性红细胞增多症（PV）、原发性血小板增多症（ET）以及继发性骨髓纤维化（pPV-MF或pET-MF）。本数据集对比了JAK2V617F突变的MPN患者与健康供者的骨髓（BM）或外周血（PB）来源CD34阳性单个核细胞的基因表达数据。本研究共分析了19例JAK2V617F突变MPN患者与6例健康对照。